Biological activities of 'noninfectious' influenza A virus particles

Future Virology

Volumn 9, Issue 1, 2014, Pages 41-51

  Brooke, Christopher B ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

aggregation; DI particles; genome packaging; influenza; noninfectious; semi infectious; virion heterogeneity; virus

Indexed keywords

EID: 84893856284     PISSN: 17460794     EISSN: 17460808     Source Type: Journal    
DOI: 10.2217/fvl.13.118     Document Type: Review

References (103)

1. Molinari NA, Ortega-Sanchez IR, Messonnier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 25(27), 5086-5096 (2007). (Pubitemid 46879994)
2. Zhang Y, Zhang Q, Kong H, et al. H5N1 hybrid viruses bearing 2009/H1N1 virus genes transmit in guinea pigs by respiratory droplet. Science 340(6139), 1459-1463 (2013).
3. Russell CA, Fonville JM, Brown AE, et al. The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science 336(6088), 1541-1547 (2012).
4. Herfst S, Schrauwen EJ, Linster M, et al. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 336(6088), 1534-1541 (2012).
5. Imai M, Watanabe T, Hatta M, et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486(7403), 420-428 (2012).
6. Lam TT, Wang J, Shen Y, et al. The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature 502(7470), 241-244 (2013).
7. Palese P, Shaw ML. Orthomyxoviridae: the viruses and their replication. In: Fields Virology. Knipe DM, Howley PM (Eds). Lippincott-Raven Publishers, PA, USA (2007).
8. Vijayakrishnan S, Loney C, Jackson D, Suphamungmee W, Rixon FJ, Bhella D. Cryotomography of budding influenza A virus reveals filaments with diverse morphologies that mostly do not bear a genome at their distal end. PLoS Pathog. 9(6), e1003413 (2013).
9. Calder LJ, Wasilewski S, Berriman JA, Rosenthal PB. Structural organization of a filamentous influenza A virus. Proc. Natl Acad. Sci. USA 107(23), 10685-10690 (2010).
10. Harris A, Cardone G, Winkler DC, et al. Influenza virus pleiomorphy characterized by cryoelectron tomography. Proc. Natl Acad. Sci. USA 103(50), 19123-19127 (2006). (Pubitemid 350002838)
11. Ghedin E, Fitch A, Boyne A, et al. Mixed infection and the genesis of influenza virus diversity. J. Virol. 83(17), 8832-8841 (2009).
12. Suarez P, Valcarcel J, Ortin J. Heterogeneity of the mutation rates of influenza A viruses: isolation of mutator mutants. J. Virol. 66(4), 2491-2494 (1992).
13. Elleman CJ, Barclay WS. The M1 matrix protein controls the filamentous phenotype of influenza A virus. Virology 321(1), 144-153 (2004). (Pubitemid 38368111)
14. Donald HB, Isaacs A. Counts of influenza virus particles. J. Gen. Microbiol. 10(3), 457-464 (1954).
15. Hutchinson EC, Curran MD, Read EK, Gog JR, Digard P. Mutational analysis of cis-acting RNA signals in segment 7 of influenza A virus. J. Virol. 82(23), 11869-11879 (2008).
16. Marcus PI, Ngunjiri JM, Sekellick MJ. Dynamics of biologically active subpopulations of influenza virus: plaque-forming, noninfectious cell-killing, and defective interfering particles. J. Virol. 83(16), 8122-8130 (2009).
17. Wei Z, McEvoy M, Razinkov V, et al. Biophysical characterization of influenza virus subpopulations using field flow fractionation and multiangle light scattering: correlation of particle counts, size distribution and infectivity. J. Virol. Methods 144(1-2), 122-132 (2007). (Pubitemid 47095043)
18. Pierson TC, Sanchez MD, Puffer BA, et al. A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection. Virology 346(1), 53-65 (2006). (Pubitemid 43254699)
19. Mukherjee S, Lin TY, Dowd KA, Manhart CJ, Pierson TC. The infectivity of prM-containing partially mature West Nile virus does not require the activity of cellular furin-like proteases. J. Virol. 85(22), 12067-12072 (2011).
20. Irmiere A, Gibson W. Isolation and characterization of a noninfectious virion-like particle released from cells infected with human strains of cytomegalovirus. Virology 130(1), 118-133 (1983). (Pubitemid 14226847)
21. Ludwig GV, Turell MJ, Vogel P, et al. Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice. Am. J. Trop. Med. Hyg. 64(1-2), 49-55 (2001). (Pubitemid 32550098)
22. Aaskov J, Buzacott K, Thu HM, Lowry K, Holmes EC. Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes. Science 311(5758), 236-238 (2006). (Pubitemid 43108190)
23. Nayak DP, Chambers TM, Akkina RK. Defective-interfering (DI) RNAs of influenza viruses: origin, structure, expression, and interference. Curr. Top. Microbiol. Immunol. 114, 103-151 (1985).
24. von Magnus P. Incomplete forms of influenza virus. Adv. Virus Res. 2, 59-79 (1954).
25. Huang AS, Baltimore D. Defective viral particles and viral disease processes. Nature 226(5243), 325-327 (1970).
26. Nayak DP. Defective interfering influenza viruses. Annu. Rev. Microbiol. 34, 619-644 (1980).
27. Janda JM, Davis AR, Nayak DP, De BK. Diversity and generation of defective interfering influenza virus particles. Virology 95(1), 48-58 (1979). (Pubitemid 9171778)
28. Kantorovich-Prokudina EN, Semyonova NP, Berezina ON, Zhdanov VM. Gradual changes of influenza virions during passage of undiluted material. J. Gen. Virol. 50(1), 23-31 (1980). (Pubitemid 11211409)
29. Nayak DP, Tobita K, Janda JM, Davis AR, De BK. Homologous interference mediated by defective interfering influenza virus derived from a temperature-sensitive mutant of influenza virus. J. Virol. 28(1), 375-386 (1978). (Pubitemid 9029995)
30. Davis AR, Hiti AL, Nayak DP. Influenza defective interfering viral RNA is formed by internal deletion of genomic RNA. Proc. Natl Acad. Sci. USA 77(1), 215-219 (1980). (Pubitemid 10142934)
31. Davis AR, Nayak DP. Sequence relationships among defective interfering influenza viral RNAs. Proc. Natl Acad. Sci. USA 76(7), 3092-3096 (1979). (Pubitemid 9233238)
32. Jennings PA, Finch JT, Winter G, Robertson JS. Does the higher order structure of the influenza virus ribonucleoprotein guide sequence rearrangements in influenza viral RNA? Cell 34(2), 619-627 (1983).
33. Janda JM, Nayak DP. Defective influenza viral ribonucleoproteins cause interference. J. Virol. 32(2), 697-702 (1979). (Pubitemid 10188788)
34. Kaverin NV, Kolomietz LI, Rudneva IA. Incomplete influenza virus: partial functional complementation as revealed by hemadsorbing cell count test. J. Virol. 34(2), 506-511 (1980). (Pubitemid 10104053)
35. Duhaut SD, Mccauley JW. Defective RNAs inhibit the assembly of influenza virus genome segments in a segment-specific manner. Virology 216(2), 326-337 (1996). (Pubitemid 26083378)
36. Duhaut SD, Dimmock NJ. Defective segment 1 RNAs that interfere with production of infectious influenza A virus require at least 150 nucleotides of 5́ sequence: evidence from a plasmid-driven system. J. Gen. Virol. 83(Pt 2), 403-411 (2002). (Pubitemid 34134248)
37. Odagiri T, Tashiro M. Segment-specific noncoding sequences of the influenza virus genome RNA are involved in the specific competition between defective interfering RNA and its progenitor RNA segment at the virion assembly step. J. Virol. 71(3), 2138-2145 (1997). (Pubitemid 27078593)
38. Odagiri T, Tominaga K, Tobita K, Ohta S. An amino acid change in the non-structural NS2 protein of an influenza A virus mutant is responsible for the generation of defective interfering (DI) particles by amplifying DI RNAs and suppressing complementary RNA synthesis. J. Gen. Virol. 75 (Pt 1), 43-53 (1994). (Pubitemid 24033979)
39. Odagiri T, Tobita K. Mutation in NS2, a nonstructural protein of influenza A virus, extragenically causes aberrant replication and expression of the PA gene and leads to generation of defective interfering particles. Proc. Natl Acad. Sci. USA 87(15), 5988-5992 (1990).
40. Fodor E, Mingay LJ, Crow M, Deng T, Brownlee GG. A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase promotes the generation of defective interfering RNAs. J. Virol. 77(8), 5017-5020 (2003). (Pubitemid 36402853)
41. Akkina RK, Chambers TM, Nayak DP. Expression of defective-interfering influenza virus-specific transcripts and polypeptides in infected cells. J. Virol. 51(2), 395-403 (1984). (Pubitemid 14091428)
42. McLain L, Armstrong SJ, Dimmock NJ. One defective interfering particle per cell prevents influenza virus-mediated cytopathology: an efficient assay system. J. Gen. Virol. 69 (Pt 6), 1415-1419 (1988).
43. Tapia K, Kim WK, Sun Y, et al. Defective viral genomes arising in vivo provide critical danger signals for the triggering of lung antiviral immunity. PLoS Pathog. 9(10), e1003703 (2013).
44. Saira K, Lin X, Depasse JV, et al. Sequence analysis of in vivo defective interfering-like RNA of influenza A H1N1 pandemic virus. J. Virol. 87(14), 8064-8074 (2013).
45. Scott PD, Meng B, Marriott AC, Easton AJ, Dimmock NJ. Defective interfering influenza virus confers only short-lived protection against influenza virus disease: evidence for a role for adaptive immunity in DI virus-mediated protection in vivo. Vaccine 29(38), 6584-6591 (2011).
46. Baum A, Sachidanandam R, Garcia-Sastre A. Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing. Proc. Natl Acad. Sci. USA 107(37), 16303-16308 (2010).
47. Hirst GK. Mechanism of influenza recombination. I. Factors influencing recombination rates between temperature-sensitive mutants of strain WSN and the classification of mutants into complementation-recombination groups. Virology 55(1), 81-93 (1973).
48. Marshall N, Priyamvada L, Ende Z, Steel J, Lowen AC. Influenza virus reassortment occurs with high frequency in the absence of segment mismatch. PLoS Pathog. 9(6), e1003421 (2013).
49. Hirst GK, Pons MW. Mechanism of influenza recombination. II. Virus aggregation and its effect on plaque formation by so-called noninfective virus. Virology 56(2), 620-631 (1973).
50. Carter MJ, Mahy BW. Incomplete avian influenza virus contains a defective non-interfering component. Arch. Virol. 71(1), 13-25 (1982). (Pubitemid 12116085)
51. Ngunjiri JM, Sekellick MJ, Marcus PI. Clonogenic assay of type a influenza viruses reveals noninfectious cell-killing (apoptosis-inducing) particles. J. Virol. 82(6), 2673-2680 (2008). (Pubitemid 351329158)
52. Marcus PI, Rojek JM, Sekellick MJ. Interferon induction and/or production and its suppression by influenza A viruses. J. Virol. 79(5), 2880-2890 (2005). (Pubitemid 40270566)
53. Ngunjiri JM, Lee CW, Ali A, Marcus PI. Influenza virus interferon-inducing particle efficiency is reversed in avian and mammalian cells, and enhanced in cells co-infected with defective-interfering particles. J. Interferon Cytokine Res. 32(6), 280-285 (2012).
54. Brooke CB, Ince WL, Wrammert J, et al. Most influenza a virions fail to express at least one essential viral protein. J. Virol. 87(6), 3155-3162 (2013).
55. Martin K, Helenius A. Transport of incoming influenza virus nucleocapsids into the nucleus. J. Virol. 65(1), 232-244 (1991).
56. Ludwig S, Pleschka S, Planz O, Wolff T. Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells. Cell. Microbiol. 8(3), 375-386 (2006). (Pubitemid 43356029)
57. Hutchinson EC, Fodor E. Transport of the influenza virus genome from nucleus to nucleus. Viruses 5(10), 2424-2446 (2013).
58. Barry RD. The multiplication of influenza virus. II. Multiplicity reactivation of ultraviolet irradiated virus. Virology 14, 398-405 (1961).
59. Ince WL, Gueye-Mbaye A, Bennink JR, Yewdell JW. Reassortment complements spontaneous mutation in influenza A virus NP and M1 genes to accelerate adaptation to a new host. J. Virol. 87(8), 4330-4338 (2013).
60. Maamary J, Pica N, Belicha-Villanueva A, et al. Attenuated influenza virus construct with enhanced hemagglutinin protein expression. J. Virol. 86(10), 5782-5790 (2012).
61. Lakadamyali M, Rust MJ, Babcock HP, Zhuang X. Visualizing infection of individual influenza viruses. Proc. Natl Acad. Sci. USA 100(16), 9280-9285 (2003). (Pubitemid 37033920)
62. de Vries E, Tscherne DM, Wienholts MJ, et al. Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway. PLoS Pathog. 7(3), e1001329 (2011).
63. Rossman JS, Leser GP, Lamb RA. Filamentous influenza virus enters cells via macropinocytosis. J. Virol. 86(20), 10950-10960 (2012).
64. Chou YY, Heaton NS, Gao Q, Palese P, Singer R, Lionnet T. Colocalization of different influenza viral RNA segments in the cytoplasm before viral budding as shown by single-molecule sensitivity FISH analysis. PLoS Pathog. 9(5), e1003358 (2013).
65. Jorba N, Coloma R, Ortin J. Genetic trans-complementation establishes a new model for influenza virus RNA transcription and replication. PLoS Pathog. 5(5), e1000462 (2009).
66. Lamb RA, Choppin PW. Synthesis of influenza virus proteins in infected cells: translation of viral polypeptides, including three P polypeptides, from RNA produced by primary transcription. Virology 74(2), 504-519 (1976).
67. Pons MW. Early RNA synthesis in influenza virus-infected cells. Virology 76(2), 855-859 (1977). (Pubitemid 8078781)
68. Bean WJ Jr, Simpson RW. Primary transcription of the influenza virus genome in permissive cells. Virology 56(2), 646-651 (1973).
69. Fodor E. The RNA polymerase of influenza a virus: mechanisms of viral transcription and replication. Acta Virol. 57(2), 113-122 (2013).
70. Parvin JD, Moscona A, Pan WT, Leider JM, Palese P. Measurement of the mutation rates of animal viruses: influenza A virus and poliovirus type 1. J. Virol. 59(2), 377-383 (1986). (Pubitemid 16013985)
71. Valcarcel J, Ortin J. Phenotypic hiding: the carryover of mutations in RNA viruses as shown by detection of mar mutants in influenza virus. J. Virol. 63(9), 4107-4109 (1989). (Pubitemid 19205496)
72. Hutchinson EC, von Kirchbach JC, Gog JR, Digard P. Genome packaging in influenza A virus. J. Gen. Virol. 91(Pt 2), 313-328 (2010).
73. Goto H, Muramoto Y, Noda T, Kawaoka Y. The genome-packaging signal of the influenza a virus genome comprises a genome incorporation signal and a genome-bundling signal. J. Virol. 87(21), 11316-11322 (2013).
74. Gavazzi C, Yver M, Isel C, et al. A functional sequence-specific interaction between influenza A virus genomic RNA segments. Proc. Natl Acad. Sci. USA 110(41), 16604-16609 (2013).
75. Fournier E, Moules V, Essere B, et al. A supramolecular assembly formed by influenza A virus genomic RNA segments. Nucleic Acids Res. 40(5), 2197-2209 (2012).
76. Noda T, Sagara H, Yen A, et al. Architecture of ribonucleoprotein complexes in influenza A virus particles. Nature 439(7075), 490-492 (2006). (Pubitemid 43152841)
77. Noda T, Sugita Y, Aoyama K, et al. Three-dimensional analysis of ribonucleoprotein complexes in influenza A virus. Nat. Commun. 3, 639 (2012).
78. Chou YY, Vafabakhsh R, Doganay S, Gao Q, Ha T, Palese P. One influenza virus particle packages eight unique viral RNAs as shown by FISH analysis. Proc. Natl Acad. Sci. USA 109(23), 9101-9106 (2012).
79. McCown MF, Pekosz A. The influenza A virus M2 cytoplasmic tail is required for infectious virus production and efficient genome packaging. J. Virol. 79(6), 3595-3605 (2005). (Pubitemid 40327948)
80. Zhang J, Leser GP, Pekosz A, Lamb RA. The cytoplasmic tails of the influenza virus spike glycoproteins are required for normal genome packaging. Virology 269(2), 325-334 (2000). (Pubitemid 30210905)
81. Spendlove RS, McClain ME, Lennette EH. Enhancement of reovirus infectivity by extracellular removal or alteration of the virus capsid by proteolytic enzymes. J. Gen. Virol. 8(2), 83-94 (1970).
82. Mindich L. Precise packaging of the three genomic segments of the double-stranded-RNA bacteriophage phi6. Microbiol. Mol. Biol. Rev. 63(1), 149-160 (1999). (Pubitemid 29116090)
83. Schiff LA, Nibert ML, Tyler KL. Orthoreoviruses and their replication. In: Fields Virology. Knipe DM, Howley PM (Eds). Lippincott-Raven Publishers, PA, USA (2007).
84. Lazarowitz SD. Plant viruses. In: Fields Virology. Knipe DM, Howley PM (Eds). Lippincott-Raven Publishers, PA, USA (2007).
85. Palese P, Tobita K, Ueda M, Compans RW. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 61(2), 397-410 (1974).
86. Rudneva IA, Kovaleva VP, Varich NL, et al. Influenza A virus reassortants with surface glycoprotein genes of the avian parent viruses: effects of HA and NA gene combinations on virus aggregation. Arch. Virol. 133(3-4), 437-450 (1993). (Pubitemid 2016440)
87. Fahy JV, Dickey BF. Airway mucus function and dysfunction. N. Engl. J. Med. 363(23), 2233-2247 (2010).
88. Crouch E, Hartshorn K, Ofek I. Collectins and pulmonary innate immunity. Immunol. Rev. 173, 52-65 (2000). (Pubitemid 30095210)
89. Verma A, White M, Vathipadiekal V, et al. Human H-ficolin inhibits replication of seasonal and pandemic influenza A viruses. J. Immunol. 189(5), 2478-2487 (2012).
90. Anders EM, Hartley CA, Jackson DC. Bovine and mouse serum beta inhibitors of influenza A viruses are mannose-binding lectins. Proc. Natl Acad. Sci. USA 87(12), 4485-4489 (1990).
91. Hartshorn K, Chang D, Rust K, White M, Heuser J, Crouch E. Interactions of recombinant human pulmonary surfactant protein D and SP-D multimers with influenza A. Am. J. Physiol. 271(5 Pt 1), L753-L762 (1996).
92. Hartshorn KL, White MR, Shepherd V, Reid K, Jensenius JC, Crouch EC. Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins. Am. J. Physiol. 273(6 Pt 1), L1156-L1166 (1997).
93. Ehre C, Worthington EN, Liesman RM, et al. Overexpressing mouse model demonstrates the protective role of Muc5ac in the lungs. Proc. Natl Acad. Sci. USA 109(41), 16528-16533 (2012).
94. Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc. Natl Acad. Sci. USA 101(13), 4620-4624 (2004). (Pubitemid 38437460)
95. Smith AM, Perelson AS. Influenza A virus infection kinetics: quantitative data and models. Wiley Interdiscip. Rev. Syst. Biol. Med. 3(4), 429-445 (2011).
96. Mitchell H, Levin D, Forrest S, et al. Higher level of replication efficiency of 2009 (H1N1) pandemic influenza virus than those of seasonal and avian strains: kinetics from epithelial cell culture and computational modeling. J. Virol. 85(2), 1125-1135 (2011).
97. Cowling BJ, Ip DK, Fang VJ, et al. Aerosol transmission is an important mode of influenza A virus spread. Nat. Commun. 4, 1935 (2013).
98. Brankston G, Gitterman L, Hirji Z, Lemieux C, Gardam M. Transmission of influenza A in human beings. Lancet Infect. Dis. 7(4), 257-265 (2007). (Pubitemid 46414066)
99. Tellier R. Aerosol transmission of influenza A virus: a review of new studies. J. R. Soc. Interface 6(Suppl. 6), S783-S790 (2009).
100. Alford RH, Kasel JA, Gerone PJ, Knight V. Human influenza resulting from aerosol inhalation. Proc. Soc. Exp. Biol. Med. 122(3), 800-804 (1966).
101. Knight V. Viruses as agents of airborne contagion. Ann. NY Acad. Sci. 353, 147-156 (1980). (Pubitemid 11185056)
102. Douglas RG. Influenza in man. In: Influenza Viruses and Influenza. Kilbourne ED (Ed.). Academic Press, Inc., NY, USA, 395-418 (1975).
103. Marcus PI, Ngunjiri JM, Sekellick MJ, Wang L, Lee CW. In vitro analysis of virus particle subpopulations in candidate live-attenuated influenza vaccines distinguishes effective from ineffective vaccines. J. Virol. 84(21), 10974-10981 (2010).